242 related articles for article (PubMed ID: 20427148)
1. Effectiveness of a mindfulness-based cognitive therapy program as an adjunct to pharmacotherapy in patients with panic disorder.
Kim B; Lee SH; Kim YW; Choi TK; Yook K; Suh SY; Cho SJ; Yook KH
J Anxiety Disord; 2010 Aug; 24(6):590-5. PubMed ID: 20427148
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of mindfulness-based cognitive therapy as an adjuvant to pharmacotherapy in patients with panic disorder or generalized anxiety disorder.
Kim YW; Lee SH; Choi TK; Suh SY; Kim B; Kim CM; Cho SJ; Kim MJ; Yook K; Ryu M; Song SK; Yook KH
Depress Anxiety; 2009; 26(7):601-6. PubMed ID: 19242985
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
Lee SH; Ahn SC; Lee YJ; Choi TK; Yook KH; Suh SY
J Psychosom Res; 2007 Feb; 62(2):189-95. PubMed ID: 17270577
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of mindfulness-based cognitive therapy for treating insomnia in patients with anxiety disorders: a pilot study.
Yook K; Lee SH; Ryu M; Kim KH; Choi TK; Suh SY; Kim YW; Kim B; Kim MY; Kim MJ
J Nerv Ment Dis; 2008 Jun; 196(6):501-3. PubMed ID: 18552629
[TBL] [Abstract][Full Text] [Related]
5. Investigating effective treatment factors in brief cognitive behavioral therapy for panic disorder.
Lim JA; Lee YI; Jang JH; Choi SH
Medicine (Baltimore); 2018 Sep; 97(38):e12422. PubMed ID: 30235717
[TBL] [Abstract][Full Text] [Related]
6. Mindfulness-based cognitive therapy for generalized anxiety disorder.
Evans S; Ferrando S; Findler M; Stowell C; Smart C; Haglin D
J Anxiety Disord; 2008 May; 22(4):716-21. PubMed ID: 17765453
[TBL] [Abstract][Full Text] [Related]
7. Psychological characteristics of early remitters in patients with panic disorder.
Park HJ; Kim EJ; Ku JI; Woo JM; Lee SH; Chung SK; Lee SY; Kim YR; Kang EH; Lee JH; Kim JH; Yu BH
Psychiatry Res; 2012 May; 197(3):237-41. PubMed ID: 22370156
[TBL] [Abstract][Full Text] [Related]
8. Panic Disorder Severity Scale: reliability and validity of the Turkish version.
Monkul ES; Tural U; Onur E; Fidaner H; Alkin T; Shear MK
Depress Anxiety; 2004; 20(1):8-16. PubMed ID: 15368591
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
Otto MW; Tolin DF; Simon NM; Pearlson GD; Basden S; Meunier SA; Hofmann SG; Eisenmenger K; Krystal JH; Pollack MH
Biol Psychiatry; 2010 Feb; 67(4):365-70. PubMed ID: 19811776
[TBL] [Abstract][Full Text] [Related]
10. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission.
Heldt E; Gus Manfro G; Kipper L; Blaya C; Isolan L; Otto MW
Behav Res Ther; 2006 May; 44(5):657-65. PubMed ID: 16038874
[TBL] [Abstract][Full Text] [Related]
11. Mindfulness-based cognitive therapy for residual depressive symptoms.
Kingston T; Dooley B; Bates A; Lawlor E; Malone K
Psychol Psychother; 2007 Jun; 80(Pt 2):193-203. PubMed ID: 17535594
[TBL] [Abstract][Full Text] [Related]
12. Web-based therapist-assisted cognitive behavioral treatment of panic symptoms: a randomized controlled trial with a three-year follow-up.
Ruwaard J; Broeksteeg J; Schrieken B; Emmelkamp P; Lange A
J Anxiety Disord; 2010 May; 24(4):387-96. PubMed ID: 20227241
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population.
Kim W; Choi YH; Yoon KS; Cho DY; Pae CU; Woo JM
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1413-8. PubMed ID: 16822601
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial.
van Aalderen JR; Donders AR; Giommi F; Spinhoven P; Barendregt HP; Speckens AE
Psychol Med; 2012 May; 42(5):989-1001. PubMed ID: 22017808
[TBL] [Abstract][Full Text] [Related]
15. Defense mechanisms after brief cognitive-behavior group therapy for panic disorder: one-year follow-up.
Heldt E; Blaya C; Kipper L; Salum GA; Otto MW; Manfro GG
J Nerv Ment Dis; 2007 Jun; 195(6):540-3. PubMed ID: 17568304
[TBL] [Abstract][Full Text] [Related]
16. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy.
Kobayashi K; Shimizu E; Hashimoto K; Mitsumori M; Koike K; Okamura N; Koizumi H; Ohgake S; Matsuzawa D; Zhang L; Nakazato M; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):658-63. PubMed ID: 15905010
[TBL] [Abstract][Full Text] [Related]
17. Cognitive-behavior therapy and the longitudinal course of panic disorder.
Otto MW; Whittal ML
Psychiatr Clin North Am; 1995 Dec; 18(4):803-20. PubMed ID: 8748382
[TBL] [Abstract][Full Text] [Related]
18. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].
Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V
Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547
[TBL] [Abstract][Full Text] [Related]
20. Anxiety sensitivity and treatment outcome in panic disorder.
Hazen AL; Walker JR; Eldridge GD
Anxiety; 1996; 2(1):34-9. PubMed ID: 9160597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
